首页> 外文OA文献 >TCT-196 Preliminary results from the DIRECT-II Study: a prospective, randomized, active-control, multi-center, non-inferiority study comparing the safety and efficacy of the Svelte drug-eluting coronary stent IDS to the Medtronic Vascular (Santa Rosa, CA) Resolute IntegrityTM DES

【2h】

TCT-196 Preliminary results from the DIRECT-II Study: a prospective, randomized, active-control, multi-center, non-inferiority study comparing the safety and efficacy of the Svelte drug-eluting coronary stent IDS to the Medtronic Vascular (Santa Rosa, CA) Resolute IntegrityTM DES

机译：TCT-196 DIRECT-II研究的初步结果：一项前瞻性，随机，主动对照，多中心，非劣效性研究，比较了Svelte药物洗脱冠状动脉支架IDS与Medtronic血管（Santa Rosa）的安全性和有效性，CA）Resolute IntegrityTM DES

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Verheye Stefan; Bartunek Jozef; berland jacques; Carrié Didier; Legrand Victor M.; Slagboom Ton; Stella Pieter R.; Van Geuns Robert J.; Vrolix Mathias;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease [J] . Seung-Pyo Lee, Jung-Won Suh, Kyung Woo Park, Trials . 2010,第1期

机译：“基于西洛他唑的三联抗血小板治疗对药物洗脱支架植入后缺血性并发症的影响”（CILON-T）的研究设计和原理：一项评估西洛他唑对药物洗脱后缺血性血管并发症疗效的多中心随机试验冠心病支架植入术
2. GW29-e2015 Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent? System) compared to TIVOLI in the Treatment of Patients with Coronary Heart Disease [J] . Yaling Han, Zhiyong Wang, Hanjun Pei, Journal of the American College of Cardiology . 2018,第16期

机译：GW29-E2015终点终点结果的前瞻性，单盲，多中心，随机，控制，临床试验，与冠心病患者的蒂沃利相比，西罗莫士洗脱支架的疗效和安全性（Mistent？系统）的疗效和安全性疾病
3. ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design [J] . DilettiR., SerruysP.W., FarooqV., The American heart journal . 2012,第5期

机译：ABSORB II随机对照试验：一项临床评估，比较Absorb洗脱依维莫司洗脱生物可吸收血管支架系统与XIENCE依维莫司洗脱冠状动脉支架系统在治疗从新引起的缺血性心脏病中的安全性，疗效和性能天然冠状动脉病变：原理和研究设计
4. Study design and rationale of Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T) study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease [O] . Seung-Pyo Lee, Jung-Won Suh, Kyung Woo Park, 2010

机译：基于西洛他唑的三联抗血小板治疗对药物洗脱支架植入后缺血性并发症的影响（CILON-T）的研究设计和原理：一项评估西洛他唑对药物洗脱后缺血性血管并发症疗效的多中心随机试验冠心病支架植入术
5. Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions) [O] . Eisenstein Eric L., Wijns William, Fajadet Jean, 2009

机译：ENDEAVOR II试验（随机对照试验评估Medtronic AVE ABT-578洗脱驾驶员冠状动脉的安全性和有效性）的努力药物洗脱支架与驾驶员裸金属支架4年结果的长期临床和经济分析De Novo原生冠状动脉病变支架）

TCT-196 Preliminary results from the DIRECT-II Study: a prospective, randomized, active-control, multi-center, non-inferiority study comparing the safety and efficacy of the Svelte drug-eluting coronary stent IDS to the Medtronic Vascular (Santa Rosa, CA) Resolute IntegrityTM DES

著录项

引文网络

相似文献

相关主题

期刊订阅